CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Nov 28, 2023. (Total: 4484 publications since 2011)

All Cancer Diabetes Economic Environmental Equity FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search CDC Author Year Journal

Records 1-8 (of 8 Records)

Query Trace: Kalman LV[original query]
CYP3A4 and CYP3A5 genotyping recommendations: A joint consensus recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , vanSchaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2023
Characterization of reference materials for CYP3A4 and CYP3A5: A genetic testing reference material coordination program collaborative project Gaedigk A , Boone EC , Turner AJ , vanSchaik RHN , Chernova D , Wang WY , Broeckel U , Granfield CA , Hodge JC , Ly RC , Lynnes TC , Mitchell MW , Moyer AM , Oliva J , Kalman LV . J Mol Diagn 2023
TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , vanSchaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2022 24 (10) 1051-1063
Characterization of Reference Materials for TPMT and NUDT15 - A GeT-RM Collaborative Project. Pratt VM , Wang WY , Boone EC , Broeckel U , Cody N , Edleman L , Gaedigk A , Lynnes TC , Medeiros E , Moyer AM , Mitchell MM , Scott SA , Starostik P , Turner A , Kalman LV . J Mol Diagn 2022 24 (10) 1079-1088
CYP2C8, CYP2C9 and CYP2C19 characterization using Next Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project. Gaedigk A , Boone EC , Scherer SE , Lee SB , Numanagi I , Sahinalp C , Smith JD , McGee S , Radhakrishnan A , Qin X , Wang WY , Farrow EG , Gonzaludo N , Halpern AL , Nickerson DA , Miller NA , Pratt VM , Kalman LV . J Mol Diagn 2022 24 (4) 337-350
Characterization of Reference Materials for CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, GGCX, and Other Pharmacogenetic Alleles with an Association for Molecular Pathology (AMP) Pharmacogenetics Working Group Tier 2 Status - A GeT-RM Collaborative Project. Pratt VM , Turner A , Broeckel U , Dawson DB , Gaedigk A , Lynnes TC , Medeiros EB , Moyer AM , Requesens D , Ventrini F , Kalman LV . J Mol Diagn 2021 23 (8) 952-958
Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen (HLA) Loci: A GeT-RM Collaborative Project. Bettinotti MP , Ferriola D , Duke JL , Mosbruger TL , Tairis N , Jennings L , Kalman LV , Monos D . J Mol Diagn 2018 20 (5) 703-715
Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology. Pratt VM , DelTredici AL , Hachad H , Ji Y , Kalman LV , Scott SA , Weck KE . J Mol Diagn 2018 20 (3) 269-276